308 related articles for article (PubMed ID: 20212262)
21. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
Wada T; Kanagawa R; Ishimura Y; Inada Y; Nishikawa K
J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841
[TBL] [Abstract][Full Text] [Related]
22. Activation of the cardiac endothelin system in left ventricular hypertrophy before onset of heart failure in TG(mREN2)27 rats.
Zolk O; Quattek J; Seeland U; El-Armouche A; Eschenhagen T; Böhm M
Cardiovasc Res; 2002 Feb; 53(2):363-71. PubMed ID: 11827687
[TBL] [Abstract][Full Text] [Related]
23. 17beta-Estradiol modulates local cardiac renin-angiotensin system to prevent cardiac remodeling in the DOCA-salt model of hypertension in rats.
Shenoy V; Grobe JL; Qi Y; Ferreira AJ; Fraga-Silva RA; Collamat G; Bruce E; Katovich MJ
Peptides; 2009 Dec; 30(12):2309-15. PubMed ID: 19747516
[TBL] [Abstract][Full Text] [Related]
24. Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism.
Ammarguellat F; Larouche I; Schiffrin EL
Circulation; 2001 Jan; 103(2):319-24. PubMed ID: 11208696
[TBL] [Abstract][Full Text] [Related]
25. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive rats.
Iyer A; Woodruff TM; Wu MC; Stylianou C; Reid RC; Fairlie DP; Taylor SM; Brown L
J Cardiovasc Pharmacol; 2011 Nov; 58(5):479-86. PubMed ID: 21753735
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension.
Iglarz M; Touyz RM; Viel EC; Paradis P; Amiri F; Diep QN; Schiffrin EL
Hypertension; 2003 Oct; 42(4):737-43. PubMed ID: 12860836
[TBL] [Abstract][Full Text] [Related]
28. Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats.
Chan V; Hoey A; Brown L
Br J Pharmacol; 2006 Aug; 148(7):902-8. PubMed ID: 16783413
[TBL] [Abstract][Full Text] [Related]
29. Impairment of the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension.
Bürgelová M; Vanourková Z; Thumová M; Dvorák P; Opocenský M; Kramer HJ; Zelízko M; Malý J; Bader M; Cervenka L
J Hypertens; 2009 Oct; 27(10):1988-2000. PubMed ID: 19593210
[TBL] [Abstract][Full Text] [Related]
30. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
Lee TM; Chen CC; Chang NC
Clin Sci (Lond); 2012 Oct; 123(7):445-57. PubMed ID: 22507072
[TBL] [Abstract][Full Text] [Related]
31. Attenuation of isoproterenol-induced cardiac fibrosis in transgenic rats harboring an angiotensin-(1-7)-producing fusion protein in the heart.
Ferreira AJ; Castro CH; Guatimosim S; Almeida PW; Gomes ER; Dias-Peixoto MF; Alves MN; Fagundes-Moura CR; Rentzsch B; Gava E; Almeida AP; Guimarães AM; Kitten GT; Reudelhuber T; Bader M; Santos RA
Ther Adv Cardiovasc Dis; 2010 Apr; 4(2):83-96. PubMed ID: 20051448
[TBL] [Abstract][Full Text] [Related]
32. Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
Hypertension; 1994 Aug; 24(2):195-204. PubMed ID: 8039844
[TBL] [Abstract][Full Text] [Related]
33. Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy.
Donohue TJ; Dworkin LD; Lango MN; Fliegner K; Lango RP; Benstein JA; Slater WR; Catanese VM
Circulation; 1994 Feb; 89(2):799-809. PubMed ID: 8313569
[TBL] [Abstract][Full Text] [Related]
34. Regulation of aortic atrial natriuretic factor and angiotensinogen in experimental hypertension.
Ogawa T; Linz W; Schölkens BA; de Bold AJ
J Cardiovasc Pharmacol; 1998 Dec; 32(6):1001-8. PubMed ID: 9869508
[TBL] [Abstract][Full Text] [Related]
35. Endothelin-A receptor blockade prevents left ventricular hypertrophy and dysfunction in salt-sensitive experimental hypertension.
Rothermund L; Vetter R; Dieterich M; Kossmehl P; Gögebakan O; Yagil C; Yagil Y; Kreutz R
Circulation; 2002 Oct; 106(18):2305-8. PubMed ID: 12403658
[TBL] [Abstract][Full Text] [Related]
36. Brain endogenous angiotensin II receptor type 2 (AT2-R) protects against DOCA/salt-induced hypertension in female rats.
Dai SY; Peng W; Zhang YP; Li JD; Shen Y; Sun XF
J Neuroinflammation; 2015 Mar; 12():47. PubMed ID: 25885968
[TBL] [Abstract][Full Text] [Related]
37. Reversal of cardiac dysfunction by selective ET-A receptor antagonism.
Allan A; Fenning A; Levick S; Hoey A; Brown L
Br J Pharmacol; 2005 Nov; 146(6):846-53. PubMed ID: 16151437
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin-(1-7) reduces cardiac effects of thyroid hormone by GSK3Β/NFATc3 signaling pathway.
Senger N; Melo MB; Diniz GP; Campagnole-Santos MJ; Santos RAS; Barreto-Chaves MLM
Clin Sci (Lond); 2018 Jun; 132(11):1117-1133. PubMed ID: 29685981
[TBL] [Abstract][Full Text] [Related]
39. Apelin effects on blood pressure and RAS in DOCA-salt-induced hypertensive rats.
Akcılar R; Turgut S; Caner V; Akcılar A; Ayada C; Elmas L; Ozcan TÖ
Clin Exp Hypertens; 2013; 35(7):550-7. PubMed ID: 23387534
[TBL] [Abstract][Full Text] [Related]
40. Attenuation of cardiovascular remodeling in DOCA-salt rats by the vasopeptidase inhibitor, omapatrilat.
Loch D; Hoey A; Brown L
Clin Exp Hypertens; 2006 Jul; 28(5):475-88. PubMed ID: 16820344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
